Cancer immunotherapy in 2017: The breakthrough of the microbiota (Q49594865)

21 February 2018

title

Cancer immunotherapy in 2017: The breakthrough of the microbiota (English)

1 reference

21 February 2018

1 reference

2

Laurence Zitvogel

1 reference

21 February 2018

Guido Kroemer

series ordinal

1

object named as

Guido Kroemer

1 reference

21 February 2018

publication date

1 January 2018

1 reference

21 February 2018

Nature Reviews Immunology

published in

1 reference

21 February 2018

volume

18

1 reference

21 February 2018

issue

2

1 reference

21 February 2018

page(s)

87-88

1 reference

21 February 2018

Mining the Human Gut Microbiota for Immunomodulatory Organisms

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2018.4

A single-cell survey of the small intestinal epithelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2018.4

Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2018.4

Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2018.4

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2018.4

Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2018.4

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2018.4

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2018.4

The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2018.4

Anticancer effects of the microbiome and its products

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2018.4

Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2018.4

31 March 2020

Identifiers

DOI

10.1038/NRI.2018.4

1 reference

21 February 2018

1 reference

21 February 2018